Dr Lucas Scott Korcek, MD | |
55 Coburg Rd, Eugene, OR 97401 | |
(541) 485-8111 | |
Not Available |
Full Name | Dr Lucas Scott Korcek |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 12 Years |
Location | 55 Coburg Rd, Eugene, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194083071 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Mckenzie-willamette Medical Center | Springfield, OR | Hospital |
Sacred Heart Medical Center - Riverbend | Springfield, OR | Hospital |
Mercy Medical Center | Roseburg, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Slocum Orthopedics Pc | 0547164758 | 64 |
News Archive
Anacor Pharmaceuticals announced today that its partner, GlaxoSmithKline (GSK), has been awarded a contract with the U.S. Department of Health and Human Services' (HHS) Biomedical Advanced Research and Development Authority (BARDA) to support the ongoing development of GSK2251052 (GSK '052, formerly AN3665), a novel boron-based Gram-negative systemic antibiotic discovered by Anacor.
The Area of Cancer and Public Health of the Foundation for the Promotion of Health and Biomedical Research of Valencia Region has been taking part in the consortium of the European Commission Innovative Partnership for Action Against Cancer since 2018.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Principio Inc., a privately held emerging company developing novel molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer, today announced that the Company has obtained an exclusive license to several technologies developed at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
› Verified 4 days ago
Entity Name | Slocum Orthopedics Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881694867 PECOS PAC ID: 0547164758 Enrollment ID: O20031120000369 |
News Archive
Anacor Pharmaceuticals announced today that its partner, GlaxoSmithKline (GSK), has been awarded a contract with the U.S. Department of Health and Human Services' (HHS) Biomedical Advanced Research and Development Authority (BARDA) to support the ongoing development of GSK2251052 (GSK '052, formerly AN3665), a novel boron-based Gram-negative systemic antibiotic discovered by Anacor.
The Area of Cancer and Public Health of the Foundation for the Promotion of Health and Biomedical Research of Valencia Region has been taking part in the consortium of the European Commission Innovative Partnership for Action Against Cancer since 2018.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Principio Inc., a privately held emerging company developing novel molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer, today announced that the Company has obtained an exclusive license to several technologies developed at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
› Verified 4 days ago
Entity Name | Cor Care Of Or, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588126650 PECOS PAC ID: 0547696882 Enrollment ID: O20200205002729 |
News Archive
Anacor Pharmaceuticals announced today that its partner, GlaxoSmithKline (GSK), has been awarded a contract with the U.S. Department of Health and Human Services' (HHS) Biomedical Advanced Research and Development Authority (BARDA) to support the ongoing development of GSK2251052 (GSK '052, formerly AN3665), a novel boron-based Gram-negative systemic antibiotic discovered by Anacor.
The Area of Cancer and Public Health of the Foundation for the Promotion of Health and Biomedical Research of Valencia Region has been taking part in the consortium of the European Commission Innovative Partnership for Action Against Cancer since 2018.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Principio Inc., a privately held emerging company developing novel molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer, today announced that the Company has obtained an exclusive license to several technologies developed at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lucas Scott Korcek, MD 55 Coburg Rd, Eugene, OR 97401-2433 Ph: (541) 485-8111 | Dr Lucas Scott Korcek, MD 55 Coburg Rd, Eugene, OR 97401 Ph: (541) 485-8111 |
News Archive
Anacor Pharmaceuticals announced today that its partner, GlaxoSmithKline (GSK), has been awarded a contract with the U.S. Department of Health and Human Services' (HHS) Biomedical Advanced Research and Development Authority (BARDA) to support the ongoing development of GSK2251052 (GSK '052, formerly AN3665), a novel boron-based Gram-negative systemic antibiotic discovered by Anacor.
The Area of Cancer and Public Health of the Foundation for the Promotion of Health and Biomedical Research of Valencia Region has been taking part in the consortium of the European Commission Innovative Partnership for Action Against Cancer since 2018.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Principio Inc., a privately held emerging company developing novel molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer, today announced that the Company has obtained an exclusive license to several technologies developed at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.
› Verified 4 days ago
Dr. Raymond Charles Ray, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 Hilyard St, Suite 230, Eugene, OR 97401 Phone: 458-205-6041 | |
Rudolf Hoellrich, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Coburg Rd, Eugene, OR 97401 Phone: 541-485-8111 Fax: 541-342-6379 | |
Olugbenga Omotayo Sulaiman, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1200 Hilyard St, Suite 600, Eugene, OR 97401 Phone: 541-485-8111 Fax: 541-342-6379 | |
Dr. Justin D Hudson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 600 Country Club Rd, Eugene, OR 97401 Phone: 541-242-4812 | |
Dr. Anna S Van Der Horst, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Coburg Rd, Eugene, OR 97401 Phone: 541-868-0873 | |
Steven Nayan Shah, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Coburg Rd, Eugene, OR 97401 Phone: 541-485-8111 Fax: 541-342-6379 | |
Jason Tavakolian, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Coburg Rd, Eugene, OR 97401 Phone: 541-485-8111 Fax: 541-342-6379 |